Abstract:To investigate the safety and effect of Tubridge flow diverter deployment for the treatment of intracranial aneurysms, 85 patients with intracranial aneurysms treated with the Tubridge flow diverter were retrospectively enrolled. The clinical data including the baseline data, aneurysm parameters before and after treatment, and follow-up outcomes were assessed. Among 85 patients, there were 35 (41.2%) males and 50 females (58.8%) aged 17–77 (mean 56.7 ± 11.1) years with 110 aneurysms. Five (5.9%) patients initially presented with subarachnoid hemorrhage from aneurysm rupture. The aneurysm size was 2–30 (mean 8.6) mm, and the aneurysm neck was 2–10.6 (mean 5.7 ± 2.3) mm. Ninety-three Tubridge stents were deployed. Twenty-five (29.4%) patients experienced adjunctive loose coiling. Blood flow was significantly reduced from entering the aneurysm after stent deployment. Periprocedural complications occurred in three (3.5%) patients, including in-stent thrombosis during embolization in one patient (1.2%), conjunctiva edema on the right in one patient (1.2%), and acute multiple cerebral infarctions in one patient (1.2%). Angiographic follow-up was conducted in 67 (78.8%) patients 3–36 (mean 15.3 ± 5.6) months later. In 11 (16.4% or 11/67) patients, blood flow still entered the aneurysm with the O'Kelly-Marotta (OKM) grade B in two (3.0%) patients and grade C in nine (13.4%), whereas complete occlusion (OKM grade D) was achieved in the other 56 (83.6% or 56/67) aneurysms. In-stent stenosis was present in five (7.5%) patients with approximately 25% stenosis in three (4.5%) patients and 50% in two (3.0%). In conclusion, the Tubridge flow diverter can be safely and efficiently applied in the treatment of small and large intracranial aneurysms, with a low periprocedural complication rate, a high occlusion degree, and a low in-stent stenosis rate at follow-up even though large aneurysms may necessitate a longer surgical time and adjunctive coiling.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the safety and efficacy of the Tubridge flow - diverting device in the treatment of intracranial aneurysms. Specifically, the researchers hope to evaluate the safety and effectiveness of this treatment method by retrospectively analyzing the clinical data of 85 patients with intracranial aneurysms treated with the Tubridge flow - diverting device, including baseline data, aneurysm parameters before and after treatment, and follow - up results.
### Research Background
Intracranial aneurysm is a serious cerebrovascular disease that may lead to subarachnoid hemorrhage and endanger the patient's life. Traditional treatment methods include craniotomy and endovascular embolization. In recent years, with the development of flow - diverting devices, more and more large, giant, and irregular - shaped aneurysms can be treated with this technology. The Tubridge flow - diverting device is a flow - diverting device independently developed in China, and its safety and efficacy in the treatment of large, giant, or recurrent intracranial aneurysms have been preliminarily verified. However, for more common small and medium - sized aneurysms, the experience in using the Tubridge device is still insufficient.
### Research Objectives
This study aims to explore the safety and efficacy of the Tubridge flow - diverting device in the treatment of common intracranial aneurysms, especially to evaluate its performance in reducing intraoperative complications, increasing the aneurysm occlusion rate, and reducing the in - stent stenosis rate.
### Main Research Contents
1. **Patient Selection**: The study included 85 patients with intracranial aneurysms who received Tubridge flow - diverting device treatment in a hospital from January 2019 to May 2022.
2. **Treatment Method**: All patients started dual - antiplatelet therapy 3 - 5 days before treatment and underwent Tubridge stent implantation through the femoral artery approach under general anesthesia. For symptomatic, large, irregular - shaped, and ruptured aneurysms, auxiliary coil embolization was also performed.
3. **Follow - up**: The treatment effects of patients were evaluated by telephone, outpatient or inpatient follow - up, and cerebral angiography. The main evaluation indicators include aneurysm occlusion (using the O’Kelly - Marotta [OKM] grading system), in - stent stenosis, and clinical prognosis (using the modified Rankin scale score).
### Research Results
- **Patient Characteristics**: Among the 85 patients, 35 were male (41.2%) and 50 were female (58.8%), with an average age of 56.7 years. There were a total of 110 aneurysms, and 5.9% of the patients had subarachnoid hemorrhage due to aneurysm rupture.
- **Treatment Effects**: All patients were successfully implanted with the Tubridge stent, and the total operation time was 140.26 ± 52.37 minutes. Immediately after the operation, the blood flow in the aneurysm was significantly reduced. The follow - up results showed that 83.6% of the aneurysms were completely occluded (OKM grade D), and 16.4% of the aneurysms still had blood flow entering (OKM grades B and C).
- **Complications**: The incidence of intraoperative complications was 3.5%, including 1 case of in - stent thrombosis, 1 case of right eye conjunctival edema, and 1 case of acute multiple cerebral infarctions. None of the patients had neurological deficits after appropriate treatment.
- **In - stent Stenosis**: In - stent stenosis occurred in 5 patients (7.5%), of which 3 cases had a stenosis degree of about 25% and 2 cases had a stenosis degree of about 50%.
### Conclusion
The research results show that the Tubridge flow - diverting device can be safely and effectively applied to the treatment of small - to - large intracranial aneurysms, with a low intraoperative complication rate, a high aneurysm occlusion rate, and a low in - stent stenosis rate. Although large aneurysms may require a longer operation time and auxiliary coil embolization, overall, the Tubridge device shows good safety and efficacy in the treatment of common intracranial aneurysms.